Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Lineage Cell Therapeutics (LCTX) Non-Current Receivables (2018 - 2019)

Historic Non-Current Receivables for Lineage Cell Therapeutics (LCTX) over the last 2 years, with Q2 2019 value amounting to $22.9 million.

  • Lineage Cell Therapeutics' Non-Current Receivables changed N/A to $22.9 million in Q2 2019 from the same period last year, while for Jun 2019 it was $22.9 million, marking a year-over-year change of. This contributed to the annual value of $22.1 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q2 2019, Lineage Cell Therapeutics' Non-Current Receivables is $22.9 million.
  • Lineage Cell Therapeutics' 5-year Non-Current Receivables high stood at $22.9 million for Q2 2019, and its period low was $21.7 million during Q3 2018.